Topical cannabinoids (CanAroma)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Topical cannabinoids (CanAroma), covering 2025-04-04 to 2025-04-04. Get the full timeline:
Most recent: Clinical Trial Update: A Feasibility Study of Topical Cannabinoids for Treatment of Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS) in Adults With Hormone Receptor-Positive Breast Cancer (CanAroma) [EARLY_Phase 1]